Enrolling 1,000 Patients

May 21, 2020

Enrolling 1,000 Patients

Clinical testing has begun on Gilead’s antiviral drug remdesivir coupled with baricitinib, an anti-inflammatory medicine. The enrollment of more than 1,000 participants is ongoing. In addition to supporting clinical trials, Yourway can also provide all ancillary materials needed during a trial, no matter how large the scale.

Back to Index

Stay Connected

Want to stay informed about the latest news, updates, and opportunities at Yourway?

Join our newsletter mailing list to never miss an update!

Media

Upcoming Events

GCSG 2026 US Conference

April 27-29, 2026
San Diego, CA

Schedule a Meeting

Pharma Supply Chain & Logistics Innovation Programme EU

May 20-21, 2026
Basel, Switzerland

Schedule a Meeting

Media

Articles

Maintaining Temperature Integrity in Direct-to-Patient Clinical Trials

Open chat

Hello! How can I help you?